Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02665195 · ClinicalTrials.gov registry record

Prospective Registry of Multiplex Testing (PROMPT)

A clinical trial of Genetic Testing, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
689
Enrollment target
10
Study locations

NCT02665195 is a study of Genetic Testing that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 689 participants, above the 548-participant average among 7 other Genetic Testing trials with a reported enrollment target (26% higher). The trial reports 10 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02665195, a study of Genetic Testing, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
689 participants
Enrollment target
10
Study locations

Study Summary

This study is being done to learn more about how changes in certain genes may be linked to cancer. Some people with cancer got their disease because they inherited an abnormal (mutated) gene. The researchers of this study want to better understand the risks that are linked to genetic changes in these less well-studied genes. By understanding these risks, we believe that doctors will be able to give better advice to families with mutations in these genes.

Conditions Studied

Genetic Testing

Interventions

  • OTHER saliva specimen
  • BEHAVIORAL questionnaire

Study Locations (10)

New York

  • Memorial Sloan Kettering Cancer Center @ Commack - Commack
  • Memorial Sloan Kettering Westchester - Harrison
  • Memorial Sloan Kettering Cancer Center - New York
  • Memorial Sloan Kettering @ Rockville - Rockville Centre

New Jersey

  • Memorial Sloan Kettering Basking Ridge - Basking Ridge
  • Memorial Sloan Kettering Monmouth - Middletown
  • Memorial Sloan Kettering Bergen - Montvale

Massachusetts

  • Dana Farber Cancer Institute - Boston

Minnesota

  • Mayo Clinic Cancer Center - Rochester

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 689 participants
Start Date 2016-01
Est. Completion 2027-01

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02665195

The ClinicalTrials.gov registry entry for NCT02665195 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 689 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 548-participant average among 7 other Genetic Testing trials with a reported enrollment target (26% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Genetic Testing appearing as the primary indexed condition, and to 2 interventions - of which saliva specimen is the first listed.

NCT02665195 reports 10 study locations spanning 5 distinct geographic areas - top geographies include New York, New Jersey, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02665195 about?

NCT02665195 is a clinical study titled "Prospective Registry of Multiplex Testing (PROMPT)". This study is being done to learn more about how changes in certain genes may be linked to cancer. Some people with cancer got their disease because they inherited an abnormal (mutated) gene. The researchers of this study want to better understand the risks that are linked to genetic changes in the...

What is the current status of trial NCT02665195?

This trial is currently active not recruiting. The enrollment target is 689 participants. The study started on 2016-01. Estimated completion is 2027-01.

What conditions does trial NCT02665195 study?

This clinical trial studies the following conditions: Genetic Testing.

What interventions are being tested in trial NCT02665195?

The interventions under investigation include: saliva specimen (OTHER), questionnaire (BEHAVIORAL).

Who is sponsoring clinical trial NCT02665195?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02665195 being conducted?

This trial has 10 study locations across Massachusetts, Minnesota, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Genetic Testing

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Genetic Testing

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.